Critics say big pharmacy benefit managers — which are parts of conglomerates that include pharmacies, providers and insurers — may conceal the size of their rebates by conducting negotiations through corporate-controlled rebate aggregators or group purchasers, mostly based overseas in tax havens, that siphon off a percentage of the cash before it goes on their books.